US Patent 7427627 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
Patent 7427627 was granted and assigned to Cyclacel Limited on September, 2008 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 11, 2006
Date of Patent
September 23, 2008
Patent Application Number
11433312
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7427627 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
